Key Concepts in Biodefense Vaccines
Preferential use of established technologies
- Low risk approach to create vaccines now
Development funding under contract - cost plus
Purchase of emergency stockpiles pre-BLA
- Probable fixed price for large supplies
- Complete purchase of stockpile on FDA license
Post licensure use in preparedness vs. response
Competition limits business opportunity vs. security of supply concerns
Interpretation of new regulations and requirements ongoing